Breast Cancer MRI Screening of Patients After Multiplex Gene Panel Testing
Leah A. Naghi(City Of Hope National Medical Center), Gregory Idos(City Of Hope National Medical Center), Rachel Hodan(Stanford Health Care), Jennifer Morales-Pichardo(City Of Hope National Medical Center), Joseph D. Bonner(Michigan Medicine), Kerry Kingham(Cargill (Netherlands)), Charité Ricker(University of Southern California), John Kidd(Myriad Genetics), Allison W. Kurian(Stanford University), Julie O. Culver(City of Hope), Meredith Mills(Stanford University), Christine Hong(City Of Hope National Medical Center), Uri Ladabaum(Stanford University), Nicolette M. Chun(Stanford University), Kevin McDonnell(City Of Hope National Medical Center), Stephen B. Gruber(University of Michigan), James M. Ford(Stanford University), Sidney S. Lindsey(City Of Hope National Medical Center), Duveen Sturgeon(City Of Hope National Medical Center)
Cited by 5
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660